Enterolactone and enterodiol, mammalian lignans derived from dietary sources such as flaxseed, sesame seeds, kale, broccoli, and apricots, may impede tumor proliferation by inhibiting activation of nuclear factor kappa B (NFjB) and vascular endothelial growth factor (VEGF). We examined the associations between urinary enterolactone and enterodiol with prostatic tumor expression of NFjB, VEGF, and Ki67 among 147 patients with prostate cancer who participated in a presurgical trial of flaxseed supplementation (30 g/day) for *30 days. Urinary enterolignans and tissue biomarkers were determined by high-performance liquid chromatography and immunohistochemistry, respectively. After supplementation, we observed significant correlations between intakes of plant lignan and urinary concentrations of total enterolignans (q = 0.677, P < .0001), enterolactone (q = 0.676, P < .0001), and enterodiol (q = 0.628, P < .0001). Importantly, we observed that total urinary enterolignans and enterolactone were significantly and inversely correlated with Ki67 in the tumor tissue (q = -0.217, P = .011, and q = -0.230, P = .007, respectively), and a near-significant inverse association was observed for enterodiol (q = -0.159, P = .064). An inverse association was observed between enterolactone and VEGF (q = -0.143, P = .141), although this did not reach statistical significance. We did not observe an association between enterolignans and NFjB. In conclusion, flaxseed-derived enterolignans may hinder cancer cell proliferation via VEGF-associated pathways.KEY WORDS: diet flaxseed lignans phytoestrogens prostatic neoplasia T he plant lignans secoisolariciresinol and matairesinol are present in legumes, cereals, fruits, and vegetables; however, flaxseed is the richest source of these phytoestrogens.1 After ingestion, secoisolariciresinol and matairesinol are converted to the enterolignans, enterolactone and enterodiol, via aerobic intestinal microflora.